Menu Back toClinical Pharmacology Approach in the Identification and Management of Adverse Drug Reactions Virtual Live Training Course

Clinical Pharmacology Approach in the Identification and Management of Adverse Drug Reactions Virtual Live Training Course

This course focuses on how to use clinical knowledge in the assessment, evaluation and management of selected Adverse Drug Reactions.


Overview

This training course, considered by many experts as one of the pillars of medical training in pharmacovigilance, focuses on how to use clinical knowledge in the assessment, evaluation and management of selected Adverse Drug Reactions (ADRs). ADRs of the main systems/organs will be presented and explained by the expert in order to provide tools to better understand and manage the serious reactions in clinical trials a well as in post authorisation.

A clinical pharmacology approach is needed for the identification, labelling and understanding of ADR mechanisms. It can also help assess the probability that a medicinal product may have played a role in the occurrence of an adverse event. This is particularly useful for the first 2 or 3 cases of serious reactions occurring during clinical trials when important decisions must be taken regarding a new drug under development.

The approach presented in this training course will take into consideration the conclusions of international or national consensus meetings on adverse drug reactions.

 

Who should attend?

This training course is designed for those who want to increase their knowledge on clinical aspects of ADRs, especially healthcare professionals involved in the monitoring and assessment of adverse drug reactions occurred in drug development or after marketing, EU–QPPV, staff in charge of pharmacovigilance and/or drug safety investigators, staff in charge of clinical trials and safety studies, clinical research associates and monitors.

 

Learning objectives

At the conclusion of this training course participants will be able to:

  • Classify and define drug-induced skin reactions, QT interval prolongation, blood disorders, drug-induced liver injury (DILI), and acute renal failure
  • Describe their clinical patterns and appropriate investigations
  • Discuss the main non drug causes of the described disorders
  • Understand how to approach causality assessment in DILI

 


TECHNICAL REQUIREMENTS

To test your system compatibility, please click on the link: https://diaglobal.zoom.us/test

Operating Systems

  • Windows: XP 32-bit (SP3), 2003, Vista 32-bit/64-bit, Windows 7 32-bit/64-bit
  • Mac OS X: 10.5, 10.6, 10.7
  • Linux: 32-bit Ubuntu 10.x,11.x 32-bit Fedora 15/16, 32-bit Red Hat 5/6, 32-bit OpenSuSE 11.4

Minimum System Requirement

  • Windows: Processor – Requires Sun Java 5 or higher, Recommend ActiveX be enabled for Internet Explorer
  • Mac OS X: Processor – JavaScript and cookies enabled, Requires Apple Java 5 or higher, No support for Remote Access
  • Linux: Processor – JavaScript and cookies enabled, Requires Apple Java 5 or higher, No support for Remote Access

Browsers

  • Windows: Internet Explorer 6, 7, 8, 9, (Win7 Only), Firefox latest (32-bit), Chrome latest
  • Mac OS X: Safari 4-Mar; Firefox 2/3/3.5
  • Linux: Mozilla 1.7, Firefox 2/3/3.5

Internet Connection Speed

  • Windows: Intel or AMD processor (1GHz or faster), At least 512 MB RAM (at least 2 GB RAM for Vista)
  • Mac OS X: Intel processor, At least 512 MB RAM
  • Linux: At least 512 MB RAM

Display

  • 800x600 pixel resolution or greater (1024x768 pixels recommended)

 

Contact us



Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics

Send Email
+41 79 333 29 76